PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsafibrinogenemia
MeSH D000347 - afibrinogenemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D025861:Inherited blood coagulation disorders
27 Companies
2 Drugs
$
Success rate
D006474:Hemorrhagic disorders
1 Company
1 Drug
$
Success rate
D020147:Coagulation protein disorders
0 Companies
0 Drugs
Success rate
D000347: 
Afibrinogenemia
2 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
CSL BehringFibrinogen, human Riastap  2009-01-16   
OctapharmaFibrinogen, human Fibryga  2017-06-07   
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
100%
2/2
Phase 3
67%
2/3
Approved: 1Overall Success rate: 67%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
CSL Behring
Fibrinogen, human,
Albumin,
Fibrinogen,
Sodium chloride,
Hipec,
Cryoprecipitate,
Demand,
Intraperitoneal,
Riastap
Octapharma
Fibrinogen, human,
Fibrinogen,
Demand,
Riastap,
Octafibrin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use